GO
Loading...

Corporate Leaders

More

  • BT CEO Resigns, Successor Picked Tuesday, 8 Apr 2008 | 11:39 AM ET

    Britain's biggest fixed-line telecoms provider, BT Group, said on Tuesday it was promoting Ian Livingston, the head of its retail business, to succeed Ben Verwaayen as chief executive.

  • Merrill CEO Does Not Plan to Raise More Capital Tuesday, 8 Apr 2008 | 10:31 AM ET
    John Thain

    U.S. investment bank Merrill Lynch does not plan to raise further capital as it has already raised more than it has lost, Chief Executive John Thain said on Tuesday.

  • Schering-Plough And The Vytorin-Zetia Backstory Monday, 7 Apr 2008 | 11:31 AM ET

    The Star-Ledger of New Jersey this weekend did a story that I think provides the best insight and backstory about what happened last week at the highest levels of Schering-Plough.CEO Fred Hassan was in Miami when doctors dropped the bomb on Vytorin and Zetia at the American College of Cardiology meeting.

  • Schering-Plough's Hell Week Friday, 4 Apr 2008 | 7:58 PM ET

    CEO Fred Hassan updates investors on his company's plans to rebound from the Vytorin debacle.

  • JPMorgan Execs to Dominate New Bank's Leadership Friday, 4 Apr 2008 | 12:14 PM ET

    JPMorgan Chase, which is taking over rival investment bankBear Stearns, will dominate the management ranks of the combined company's investment banking and trading businesses, according to an internal memo.

  • When you're stressed, do you hit the bar or hit the gym? Do you drink whiskey or wheatgrass? Lululemon Athletica's incoming CEO Christine Day says that one strategic advantage of the high-priced yoga wear line is that during an economic downturn, people choose things to relieve that stress--like working out.

  • Amgen's Bone Drug Data: Is There "Bone Of Contention"? Thursday, 3 Apr 2008 | 11:05 AM ET
    AMGEN

    After the closing bell yesterday, Amgen put out a press release announcing that phase 3 pivotal data are being published in a scientific/medical journal about its most important drug development pipeline product--an osteoporosis drug known as D-mab. (Whenever you see the letters mab at the end of the scientific name for a drug it means it's a monoclonal antibody).

  • Arch's Coal Is Already Clean Wednesday, 2 Apr 2008 | 7:08 PM ET

    Forget ethanol – this company’s got an alternative for the alternative.

  • Is Medco Healthy? Tuesday, 1 Apr 2008 | 6:52 PM ET

    Cramer went right to the source to find out. Let the CEO explain.

  • Vytorin Battle Pits Merck/Schering-Plough Vs Pfizer Tuesday, 1 Apr 2008 | 11:03 AM ET

    Given investor reaction to the Vytorin/Zetia news yesterday, you might draw the conclusion the huge cholesterol drug franchise might be doomed. Sure, analysts say, prescriptions and sales are gonna go down some more, but they're not going to zero.

  • Schering CEO Speaks on Vytorin Monday, 31 Mar 2008 | 6:59 PM ET

    "We stand behind our product," Fred Hassan says. But does Cramer?

  • Where There's a Willbros, There's a Way Friday, 28 Mar 2008 | 6:49 PM ET

    The CEO of the engineering company tells Cramer what he's doing to dominate the oil and gas market.

  • When I heard a soundbite with Sen. Hillary Clinton on CNBC's "Kudlow & Company" last night, it reminded me to check and see if the Center for Responsive Politics had updated its monthly campaign contribution data.

  • Ex-Bear Exec Can't Join Morgan Stanley: Judge Friday, 28 Mar 2008 | 7:03 AM ET

    A U.S. federal judge has temporarily blocked a former senior Bear Stearns executive from jumping to Morgan Stanley and recruiting clients and colleagues to follow him.

  • Countrywide Financial

    Bank of America said it has agreed to pay $28 million to Countrywide Financial Chief Operating Officer David Sambol to induce him to run the merged companies' consumer mortgage operations.

  • Biovail's Travails Drag "60 Minutes" Into Controversy Thursday, 27 Mar 2008 | 4:09 PM ET
    BIOVAIL

    The Columbia Journalism Review, the pre-eminent publication and authority on what we in the business refer to as "The Big J"--as in Journalism--is calling out CBS' "60 Minutes" in an article just posted on the web with the somewhat explosive headline, "60 Minutes Blows Biovail Story."

  • General Mills CEO: Food Inflation Will 'Moderate' Thursday, 27 Mar 2008 | 3:42 PM ET

    But a global economic boom will keep at least some prices up.

  • Buy U.S. Steel Wednesday, 26 Mar 2008 | 7:22 PM ET

    While the rest of the sector was going bankrupt, this company thrived. No wonder it's Cramer's favorite in the group.

  • Bogle: Stock Returns Will Stay 'Subdued' for Years Wednesday, 26 Mar 2008 | 2:54 PM ET

    Vanguard founder and former CEO John Bogle told CNBC that he expects the stock market's meager returns to continue for some time. "Be mentally prepared for some pretty slovenly going--some subdued returns--for quite a few years," Bogle said.

  • Bear Stearns' Amgen Call  Brings On More Gallows Humor Wednesday, 26 Mar 2008 | 1:16 PM ET

    This morning, Bear Stearns biotech analyst Mark Schoenebaum and a couple of members of his research team hosted a conference call with a 50-page PowerPoint about Amgen. The purpose was to drill down into the looming court decision over whether Roche will be able to launch a competing anemia drug in the U.S. for kidney dialysis patients.